DoD Peer Reviewed Cancer Research Program

Amount of funding: Direct costs budgeted for the entire period of performance will not exceed $400,000 or $200,000 for a CDA-RO Award Research Level 1.
Purpose:  The PRCRP is seeking to advance cancer research through development of early-career investigators. Depending on the career path of the candidates, the PRCRP will offer two distinct early-career development options: the Career Development Award-Fellow Option (CDA-FO) and the Career Development Award-Resident Option (CDA-RO). Under this award mechanism, the early-career investigator is considered the Principal Investigator (PI), and the application should focus on the PI’s research and career development.
Eligibility: Early career faculty with PI eligibility and CE faculty may be the PI.  Investigator (early-career researcher or physician-scientist) at or above the level of Research Assistant Professor or Instructor (or equivalent). CE faculty and Instructors must obtain a Career Development PI waiver through their RPM in RMG prior to the pre-application/letter of intent. PI must be at least at the level of assistant professor (see program guidelines for additional eligibility information).  Must be within 7 years after completion of their terminal degree by the time of the application submission deadline (excluding time spent in residency, clinical training, or on family medical leave). 
Not eligible: Postdocs and Clinical fellows are not eligible. 
Timeline:
Pre-Application (Letter of Intent) Submission Deadline: July 25, 2023 via eBrap
Please include your RPM’s name as business official in the pre-application.
Institutional representative (RPM/RMG or CGO/OSR) Deadline: August 3, 2023
Application submission Deadline: August 10, 2023 via grants.gov
Guidelines: https://cdmrp.army.mil/funding/prcrp

Amount of funding: Direct costs budgeted for the entire period of performance will not exceed $400,000 or $200,000 for a CDA-RO Award Research Level 1.
Purpose:  The PRCRP is seeking to advance cancer research through development of early-career investigators. Depending on the career path of the candidates, the PRCRP will offer two distinct early-career development options: the Career Development Award-Fellow Option (CDA-FO) and the Career Development Award-Resident Option (CDA-RO). Under this award mechanism, the early-career investigator is considered the Principal Investigator (PI), and the application should focus on the PI’s research and career development.
Eligibility: The Resident must be in an accredited graduate medical education program with an institutional letter of support. The Resident must be able to commit 1 or 2 years within the time frame from approximately June 2024-2026 toward research with the level of effort on the proposed research appropriate for the research funding level and the project. The Resident’s organization must demonstrate a commitment to the Resident through confirmation of laboratory space.  CE faculty and Instructors must obtain a Career Development PI waiver through their RPM in RMG prior to the pre-application/letter of intent.
Not eligible: Postdocs and Clinical fellows are not eligible. 
Timeline:
Pre-Application (Letter of Intent) Submission Deadline: July 25, 2023 via eBrap
Please include your RPM’s name as business official in the pre-application.
Institutional representative (RPM/RMG or CGO/OSR) Deadline: August 3, 2023
Application submission Deadline: August 10, 2023 via grants.gov
Guidelines: https://cdmrp.army.mil/funding/prcrp

Amount of funding: Direct costs budgeted for the entire period of performance will not exceed $400,000.
Purpose:  The FY23 PRCRP Idea Award supports innovative, untested, high-risk/potentially high-reward concepts, theories, paradigms, and/or basic cancer research that are relevant to active-duty Service Members, Veterans, other military beneficiaries, and the American public. The advancement of knowledge in cancer research, patient care, and/or treatment options in the MHS is critical to active-duty Service Members, Veterans, other military beneficiaries, and the American public.
Eligibility: Independent investigators - Faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver obtained through their RPM in RMG prior to the pre-application/letter of intent) may be the PI. 
Not eligible: Instructors, Clinical Instructors, Academic Staff-Research (i.e., research associates), Postdocs, and Clinical fellows are not eligible.
Timeline:
REQUIRED Pre-Application (Pre-Proposal) Deadline: May 25, 2023 via eBrap
Please include your RPM’s name as business official in the pre-application.
Institutional representative (RPM/RMG or CGO/OSR) Deadline:  September 5, 2023
Application Submission Deadline: September 12, 2023 via grants.gov
Guidelines: https://cdmrp.army.mil/funding/prcrp

Amount of funding: Direct costs s budgeted for the entire period of performance will not exceed $1M.
Purpose:  The FY23 PRCRP Impact Award supports hypothesis-driven, high-impact research. The intent of the Impact Award mechanism is to fund mature research projects that specifically focus on critical scientific or clinical cancer issues, which have the potential to make a major near-term impact on at least one of the FY23 PRCRP Topic Areas. Important factors under consideration will be continuity of research, clinical applicability, and leveraging of clinical samples and trials. The Impact Award supports identifying scientific outcomes that, through rigorous, robust research, are translatable toward treatment and/or preventive strategies. Research proposed should aim to accelerate promising findings toward clinical applicability and leverage research results to maximize impact.  
Eligibility: Independent investigators - Faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver obtained through their RPM in RMG prior to the pre-application/letter of intent) may be the PI.   
Not eligible: Instructors, Clinical Instructors, Academic Staff-Research (i.e., research associates), Postdocs, and Clinical fellows are not eligible.
Timeline:
REQUIRED Pre-Application (Pre-Proposal) Deadline: May 25, 2023 via eBrap
Please include your RPM’s name as business official in the pre-application.
Institutional representative (RPM/RMG or CGO/OSR) Deadline:  September 5, 2023
Application Submission Deadline: September 12, 2023 via grants.gov
Guidelines: https://cdmrp.army.mil/funding/prcrp

Amount of funding: Direct costs budgeted for the entire period of performance will not exceed $3M.
Purpose:  The PRCRP ACCCT Award supports clinical trials that will progress to the next stage of study or improve the standard of care for individuals living with cancer within at least one of the FY23 PRCRP Topic Areas. The ACCCT Award mechanism requires a clinical trial for transition of and the advancement of previously completed pre-clinical research to the clinic. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first in human, phase 0) to demonstrate the feasibility or inform the design of more advanced trials through large-scale trials to determine efficacy in relevant patient populations.
Eligibility: Independent investigators - Faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver obtained through their RPM in RMG prior to the pre-application/letter of intent) may be the PI.  
Not eligible: Instructors, Clinical Instructors, Academic Staff-Research (i.e., research associates), Postdocs, and Clinical fellows are not eligible.
Timeline:
REQUIRED Pre-Application (Pre-proposal) Deadline: May 25, 2023 via eBrap
Please include your RPM’s name as business official in the pre-application.
Institutional representative (RPM/RMG or CGO/OSR) Deadline: September 20, 2023 
Application submission Deadline: September 27, 2023 via grants.gov
Guidelines: https://cdmrp.army.mil/funding/prcrp

Amount of funding: Direct costs budgeted for the entire period of performance will not exceed $2.5M.
Purpose:  The FY23 PRCRP TTSA supports hypothesis-driven translational studies. These studies must be associated with ongoing or completed clinical trial. The proposed project should focus on research for the next-phase clinical trial or future clinical application. The TTSA is intended to support advanced translational studies that are based on results from clinical investigations and to utilize information from the clinical trials for research that would then inform the clinic. While funding for clinical trials is allowed, the TTSA is intended to support multi-investigator, multidisciplinary teams to perform clinical research studies and not only to fund a clinical trial. 
Eligibility: Independent investigators - Faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver obtained through their RPM in RMG prior to the pre-application/letter of intent) may be the PI or Partnering PI.  PIs must be at least at the level of Assistant Professor (see program guidelines for additional eligibility information).
Not eligible: Instructors, Clinical Instructors, Academic Staff-Research (i.e., research associates), Postdocs, and Clinical fellows are not eligible.
Timeline:
Pre-Application (Letter of Intent) Submission Deadline: July 25, 2023 via eBrap
Please include your RPM’s name as business official in the pre-application.
Institutional representative (RPM/RMG or CGO/OSR) Deadline: August 3, 2023
Application submission Deadline: August 10, 2023 via grants.gov
Guidelines: https://cdmrp.army.mil/funding/prcrp

Amount of funding: Direct costs budgeted for the entire period of performance will not exceed $1M.
Purpose:  The Patient Well-Being and Survivorship Award (PWSA) supports innovative research studies to advance studies in preservation of function (physical ability), quality of life, symptom management, resilience, relief from neurocognitive deficits, and support for psychosocial issues related to cancer diagnosis, treatment, and survivorship. Studies must address one or more of these critical issues in at least one of the FY23 PRCRP Topic Areas. 
Eligibility: Independent investigators - Faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver obtained through their RPM in RMG prior to the pre-application/letter of intent) may be the PI.
Not eligible: Instructors, Clinical Instructors, Academic Staff-Research (i.e., research associates), Postdocs, and Clinical fellows are not eligible.
Timeline:
Pre-Application (Letter of Intent) Submission Deadline: July 25, 2023 via eBrap
Please include your RPM’s name as business official in the pre-application.
Institutional representative (RPM/RMG or CGO/OSR) Deadline: August 3, 2023
Application submission Deadline: August 10, 2023 via grants.gov
Guidelines: https://cdmrp.army.mil/funding/prcrp

Please include your institutional official's name (RPM/RMG or CGO/OSR) as business official in the pre-application/LOI.

eBRAP Funding Opportunities and Forms (including the General Application Instructions).